Amedica Signs Agreement with Kyocera for Commercial Manufacture of Silicon Nitride Medical Devices

  Amedica Signs Agreement with Kyocera for Commercial Manufacture of Silicon
                           Nitride Medical Devices

PR Newswire

SALT LAKE CITY, Nov. 26, 2013

SALT LAKE CITY, Nov. 26, 2013 /PRNewswire/ --Amedica Corporation,
abiomaterials company, today announced a collaboration with Kyocera
Industrial Ceramics Corporation, a worldwide leading ceramics producer, to
manufacture medical devices from Amedica's Silicon Nitride biomaterial at
Kyocera's Vancouver, WA facility. This collaboration includes the manufacture
of Amedica's FDA approved Silicon Nitride spinal interbody devices and will
broaden Amedica's ability to meet market demand.

As a biomaterial, Silicon Nitride has been shown to help promote bone growth
and has anti-infective properties. Devices made from Silicon Nitride are
semi-radiolucent with clearly visible boundaries enabling an exact view of
intraoperative placement and postoperative fusion assessment via common
imaging modalities. Amedica believes that these are essential characteristics
that surgeons seek when choosing the ideal spinal interbody implant for their
patients. Amedica has sold over 14,000 of these devices worldwide.

Eric Olson, President and CEO of Amedica Corporation, says, "There is an unmet
need for advanced biomaterials in Orthopedics and Spine. We are seeing an
increasing interest for our Silicon Nitride interbody devices and increased
interest in this material for use in other applications and want to ensure a
consistent supply for surgeons and more importantly, patients. As the world's
numberone producer of advanced ceramics* with vast experience in ensuring
market demand is consistently fulfilled for innovative products, Kyocera is
the ideal partner to help broaden availability of our novel biomaterial
devices."

About Amedica Corporation

Amedica is a commercial biomaterial company focused on using its Silicon
Nitride technology platform to develop, manufacture and sell a broad range of
medical devices. Amedica markets spinal fusion products and is developing
product candidates for use in total hip and knee joint replacements. Amedica
is a privately owned company founded in 1996. The company operates an ISO
13485 certified manufacturing facility, and, its spine products are FDA
cleared, CE marked, and are currently marketed in the US and select markets in
Europe and South America. Amedica is based in Salt Lake City, Utah.

About KYOCERA

Kyocera Industrial Ceramics Corporation (www.kyocera.com/kicc), headquartered
in Hendersonville, NC, specializes in applying advanced ceramic materials and
components to solve the most demanding engineering challenges. It is a
wholly-owned subsidiary of Kyocera International, Inc. of San Diego, the North
American holding company for Kyocera Corporation.

Kyocera Corporation (NYSE:KYO) (TOKYO: 6971) (http://global.kyocera.com/), the
parent and global headquarters of the Kyocera Group, was founded in 1959 as a
producer of fine ceramics (also known as "advanced ceramics"). By combining
these engineered materials with metals and plastics, and integrating them with
other technologies, Kyocera has become a leading supplier of advanced ceramic
components, medical products, solar power generating systems,
telecommunications equipment, printers, copiers, electronic components,
semiconductor packages and cutting tools. During the year ended March 31,
2013, the company's net sales totaled 1.28 trillion yen (approx. USD13.6
billion). The company is ranked #492 on Forbes magazine's 2013 "Global 2000"
listing of the world's largest publicly traded companies.

*http://www.ceramicindustry.com/articles/93444-ci-top-10-advanced-ceramic-manufacturers

Media Contacts
Erika Kuzmicz
Schwartz MSL
(781) 684-0770
AMEDICA@schwartzmsl.com



SOURCE Amedica Corporation

Website: http://amedica.com